Details for 2019801443

Up to date per 05.04.2026

Actions

Title / Product Name

2,3,5-TRIMETHYL-6-NONYLCYCLOHEXA-2,5-DIEN-1,4-DION ZUR UNTERDRÜCKUNG UND BEHANDLUNG VON ALPHA-SYNUCLEINOPATHIEN, TAUOPATHIEN UND ANDEREN ERKRANKUNGEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2019801443

EP Publication Number

3866772

E-Number

1619537

Language

PCT Number

US19056836

Publication Date

25.08.2021 A

11.10.2023 B1

Registration Date

11.10.2023

AT Publication Date

15.11.2023

Application Date

17.10.2019

Registration Number

Priorities

17.10.2018

201862747080 P

26.11.2018

201862771570 P

IPC

A61K 31/05 20060101AFI20210518BHEP

Maximum Duration of Protection

17.10.2039

Owner

PTC Therapeutics, Inc.100 Corporate Court Middlesex Business Center South Plainfield, New Jersey 07080US

Representative

No representatives present

Inventor

HINMAN, Andrew W.c/o PTC Therapeutics, Inc. 100 Corporate Court Middlesex Business Center South Plainfield, New Jersey 07080US

HOLST, Charles R.c/o PTC Therapeutics, Inc. 100 Corporate Court Middlesex Business Center South Plainfield, New Jersey 07080US

MINELLA, Angelac/o PTC Therapeutics, Inc. 100 Corporate Court Middlesex Business Center South Plainfield, New Jersey 07080US

MOLLARD, Paulc/o PTC Therapeutics, Inc. 100 Corporate Court Middlesex Business Center South Plainfield, New Jersey 07080US

PINTCHOVSKI, Seanc/o PTC Therapeutics, Inc. 100 Corporate Court Middlesex Business Center South Plainfield, New Jersey 07080US

TRIMMER, Jeffrey K.c/o PTC Therapeutics, Inc. 100 Corporate Court Middlesex Business Center South Plainfield, New Jersey 07080US

TORREY, Eric300-1489 Hollis St. Halifax, Nova Scotia B3J 3M5CA